Showing results (21-30 of 360) with videos related to
Sort By:
Pageof 36
Cancer Research|January 21, 2006
Targeting cell-impermeable prodrug activation to tumor microenvironment eradicates multiple drug-resistant neoplasmsWenyuan Wu, Yunping Luo, Chengzao Sun, et al.Pharmacology, Biochemistry, and Behavior|November 23, 2007
MPZP: a novel small molecule corticotropin-releasing factor type 1 receptor (CRF1) antagonistHeather N Richardson, Yu Zhao, Eva M Fekete, et al.Journal of the American Chemical Society|February 24, 2005
Fluorescent cocaine probes: a tool for the selection and engineering of therapeutic antibodiesMichael M Meijler, Gunnar F Kaufmann, Longwu Qi, et al.Journal of the American Chemical Society|August 13, 2008
Characterization of a chiral enolate aggregate and observation of 6Li-1H scalar couplingDeyu Li, Chengzao Sun, Paul G WilliardBioorganic & Medicinal Chemistry|February 12, 2002
Histidine kinases as targets for new antimicrobial agentsMasayuki Matsushita, Kim D JandaScientific Reports|September 17, 2016
Reprofiled anthelmintics abate hypervirulent stationary-phase Clostridium difficileMajor Gooyit, Kim D JandaAnalytica Chimica Acta|July 4, 2026
Label-free quantification of cumulative cytosol-enriched peptide concentrations by mass spectrometryMona Sharar, Heather Pascual, Chengzao Sun, et al.Chembiochem : a European Journal of Chemical Biology|January 22, 2011
Shedding light on the ghrelin/GOAT metabolism sagaAmanda L Garner, Kim D JandaChemical Communications (Cambridge, England)|May 20, 2011
A small molecule antagonist of ghrelin O-acyltransferase (GOAT)Amanda L Garner, Kim D JandaPharmacology, Biochemistry, and Behavior|April 8, 2009
Immunopharmacotherapy: vaccination strategies as a treatment for drug abuse and dependenceAmira Y Moreno, Kim D JandaPageof 36